Healing System Articles & Analysis
8 news found
Historically, natural products have played a pivotal role in traditional healing systems, and modern science continues to exploit these compounds for their therapeutic potentials, particularly in combating cancerous and infectious diseases. ...
These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." Diverse Product Offering: Biopharma PEG’s multi-arm PEG products are available with various branching structures and functional groups to meet the specific needs of researchers and developers in the medical and bioorganic ...
Aurealis Therapeutics, a synthetic biology company developing ground-breaking four-in-one cell and gene therapies, announced today the publication of the first study on its investigational product AUP-16, a four-in-one -combination therapy using live Lactococcus lactis expressing three human therapeutic proteins for the treatment of chronic non-healing wounds. This announcement comes as the ...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat (ENT) medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT for $28.25 per share in an all-cash transaction implying ...
The combination of SANUWAVE’s dermaPACE® System and the UltraMIST® System – acquired from Celularity, Inc., in 2020 – is the basis for its “Energy First” protocol for wound healing. ...
Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTCTM for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic ...
In partnership with Mesoblast Limited, JCR Pharmaceuticals has filed to extend the marketing approval of TEMCELL, a mesenchymal stem cell (MSC) wound healing product for patients with Epidermolysis Bullosa (EB). JCR has received an orphan drug designation for subcutaneous treatment of TEMCELL for EB, and are currently seeking a label extension for intravenous delivery of TEMCELL in Japan. There ...
ByIMAPAC
Doctors put the sheath into the artery through the hole in the artery wall. They then use the delivery system to push the patch out of the end of the sheath into the artery. As the doctor pulls the system out of the artery, the patch sits against the arterial wall. Once this happens, the spheres are uncovered in the space outside the artery. ...